Log in to your Inderes Free account to see all free content on this page.
ALK-Abelló
238.40 DKK
+1.53 %
Less than 1K followers
ALK B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ALK-Abelló
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 81.75 | 125.00 | 171.50 | 96.05 | 101.20 | 159.10 | 228.60 |
| Shares | 202.6 | 217.7 | 222.8 | 222.8 | 222.8 | 222.8 | 221.6 |
| Market cap | 16,559.3 | 27,215.0 | 38,213.6 | 21,402.2 | 22,549.8 | 35,451.3 | 50,649.2 |
| Enterprise value | 17,549.3 | 28,158.0 | 38,729.6 | 21,877.2 | 22,840.8 | 36,049.3 | - |
| EV/S | 5.4 | 8.1 | 9.9 | 4.8 | 4.7 | 6.5 | - |
| EV/EBITDA | 72.8 | 71.3 | 72.5 | 30.9 | 25.1 | 26.4 | - |
| EV/EBIT | neg. | 187.7 | 132.6 | 46.5 | 34.3 | 33.0 | - |
| P/E | neg. | 1,088.6 | 174.5 | 63.2 | 46.0 | 43.2 | 42.3 |
| P/B | 5.21 | 8.63 | 10.98 | 5.37 | 5.07 | 6.60 | 7.86 |
| P/S | 5.1 | 7.8 | 9.8 | 4.7 | 4.7 | 6.4 | 8.0 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.7 % |
| Equity ratio | 57.8 % | 56.7 % | 59.7 % | 63.2 % | 66.1 % | 65.2 % | 71.2 % |
| Gearing ratio | 39.5 % | 23.3 % | 20.4 % | 17.5 % | 17.2 % | 22.1 % | 6.5 % |
Login required
This content is only available for logged in users